COSMO Pharmaceuticals SA (0RGI) — Cash Flow-to-Debt Ratio
COSMO Pharmaceuticals SA (0RGI) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of £900.00K could theoretically repay 0% of its total liabilities (£143.35 Million) in one year. Check 0RGI cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
COSMO Pharmaceuticals SA Cash Flow-to-Debt Ratio (2004–2024)
Historical debt coverage capacity for COSMO Pharmaceuticals SA across 21 annual periods. Also explore COSMO Pharmaceuticals SA (0RGI) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for COSMO Pharmaceuticals SA (2004–2024)
Year-by-year debt coverage analysis for COSMO Pharmaceuticals SA. For market capitalisation and broader financial context, see market value of COSMO Pharmaceuticals SA.
| Year | CF-to-Debt Ratio | Operating CF (GBP) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.15x | £162.41 Million | £141.68 Million | ▲ +530.7% |
| 2023 | 0.18x | £22.71 Million | £124.94 Million | ▲ +63.4% |
| 2022 | 0.11x | £32.89 Million | £295.80 Million | ▲ +158.3% |
| 2021 | 0.04x | £12.61 Million | £292.88 Million | ▼ -35.0% |
| 2020 | 0.07x | £12.98 Million | £196.04 Million | ▲ +167.3% |
| 2019 | -0.10x | £-18.85 Million | £191.43 Million | ▼ -75.2% |
| 2018 | -0.06x | £-10.16 Million | £180.83 Million | ▲ +84.4% |
| 2017 | -0.36x | £-10.01 Million | £27.86 Million | ▼ -138.0% |
| 2016 | 0.95x | £26.41 Million | £27.92 Million | ▲ +182.7% |
| 2015 | -1.14x | £-39.23 Million | £34.30 Million | ▼ -226.2% |
| 2014 | 0.91x | £66.45 Million | £73.33 Million | ▲ +155.2% |
| 2013 | 0.36x | £8.11 Million | £22.85 Million | ▼ -57.9% |
| 2012 | 0.84x | £23.00 Million | £27.24 Million | ▲ +9.2% |
| 2011 | 0.77x | £11.29 Million | £14.60 Million | ▲ +232.2% |
| 2010 | 0.23x | £7.79 Million | £33.46 Million | ▼ -29.9% |
| 2009 | 0.33x | £3.88 Million | £11.67 Million | ▲ +138.6% |
| 2008 | -0.86x | £-12.52 Million | £14.53 Million | ▼ -312.9% |
| 2007 | -0.21x | £-2.52 Million | £12.08 Million | ▼ -162.7% |
| 2006 | 0.33x | £6.08 Million | £18.27 Million | ▲ +439.9% |
| 2005 | 0.06x | £1.70 Million | £27.58 Million | ▲ +474.9% |
| 2004 | 0.01x | £261.00K | £24.34 Million | — |